Early research (Phase 1)WithdrawnNCT02661659
What this trial is testing
A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy
Who this might be right for
Malignant Pleural Mesothelioma (MPM)
University of Chicago